- Home
- XFOR vs RRGB Comparison
XFOR vs RRGB Comparison
Compare XFOR & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XFOR
- RRGB
- Stock Information
- Founded
- XFOR 2014
- RRGB 1969
- Country
- XFOR United States
- RRGB United States
- Employees
- XFOR N/A
- RRGB N/A
- Industry
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- RRGB Restaurants
- Sector
- XFOR Health Care
- RRGB Consumer Discretionary
- Exchange
- XFOR Nasdaq
- RRGB Nasdaq
- Market Cap
- XFOR 84.3M
- RRGB 88.7M
- IPO Year
- XFOR N/A
- RRGB 2002
- Fundamental
- Price
- XFOR $3.64
- RRGB $6.23
- Analyst Decision
- XFOR Strong Buy
- RRGB Strong Buy
- Analyst Count
- XFOR 3
- RRGB 2
- Target Price
- XFOR $34.17
- RRGB $11.00
- AVG Volume (30 Days)
- XFOR 10.6M
- RRGB 358.4K
- Earning Date
- XFOR 08-08-2025
- RRGB 08-13-2025
- Dividend Yield
- XFOR N/A
- RRGB N/A
- EPS Growth
- XFOR N/A
- RRGB N/A
- EPS
- XFOR N/A
- RRGB N/A
- Revenue
- XFOR $32,774,000.00
- RRGB $1,235,920,000.00
- Revenue This Year
- XFOR $1,313.84
- RRGB N/A
- Revenue Next Year
- XFOR N/A
- RRGB N/A
- P/E Ratio
- XFOR N/A
- RRGB N/A
- Revenue Growth
- XFOR 5721.31
- RRGB N/A
- 52 Week Low
- XFOR $1.35
- RRGB $2.50
- 52 Week High
- XFOR $26.83
- RRGB $7.89
- Technical
- Relative Strength Index (RSI)
- XFOR 51.62
- RRGB 50.50
- Support Level
- XFOR $3.57
- RRGB $6.42
- Resistance Level
- XFOR $4.83
- RRGB $6.72
- Average True Range (ATR)
- XFOR 0.55
- RRGB 0.40
- MACD
- XFOR -0.05
- RRGB -0.01
- Stochastic Oscillator
- XFOR 26.94
- RRGB 20.83
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.